rebat guarante new come focu despit newer
scrutini around rebat guarante speak dynam
rebat guarante underwritten sell season
along contract initi begin sell
season assumpt higher brand inflat histor hsd
vs current estimate msd note began refin new contract
incorpor protect brand inflat dynam said
sell season view primarili health plan contract
typic final call still expos unfavor
commit importantli size exposur
highlight limit cohort contract expos rebat guarante
dissect rebat guarante impact reduc pbm oper
profit guid lower end prior rang lsd-msd growth
impli estim million impact attribut client commit
factor undoubtedli work mitig impact
futur period continu expect rebat guarante headwind
lower brand drug inflat environ said highlight
brand drug inflat except low manufactur
resum price increas estimate msd like mitig
potenti impact moreov contract come renew like
magnitud sell season sell season
billion dilig appli adjust underwrit model
moder risk go-forward basi els equal analysi
purpos estim bp declin brand price inflat
rel relev pbm contract expect could drive potenti
hit ep albeit includ potenti brand price implic
segment well potenti offset
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
caremark corpor caremark pharmaci
healthcar provid unit state provid pharmaci
servic pharmaci benefit manag pbm mail
order specialti pharmaci divis caremark pharmaci
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
better fundament perform sentiment could drive upsid
target price blue sky scenario
weaker fundament perform sentiment could lead
downsid versu target price grey sky scenario
 close
refin model ep unchang updat model reflect weaker pbm
profit lower brand price inflat environ well impact higher
interest expens off-set better enrol growth aetna see note aetna
growth engin lower pro forma share base specif consist
recent compani disclosur rais interest expens estim
